跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,930 条关于
“Diffuse midline glioma”
全部
4,930
临床试验
4,169
药物
48
机构
20
资讯
693
2年前
CAR T-cell Therapies Show Promise in Treating Diffuse Midline Glioma
去年
FDA Approves Modeyso as First Treatment for Recurrent H3 K27M-Mutant Diffuse Midline Glioma
去年
FDA Grants First Accelerated Approval for H3 K27M-Mutated Diffuse Midline Glioma with Dordaviprone
4个月前
HealthCare Royalty Secures Modeyso Royalty Rights Following Strong Early Commercial Performance
去年
GD2-Directed CAR T-Cell Therapy Shows Promise in Pediatric Brain Cancer with Complete Response in One Patient
去年
Dordaviprone Shows Promise in Recurrent H3 K27M-Mutant Glioma: Updated Phase 2 Data
去年
MTX110 Shows Promise in Recurrent Glioblastoma: Phase 1 Data
去年
CAR T-Cell Therapy Shows Promise in Treating Deadly Childhood Brain Tumors
去年
CAR-T Cell Therapy Shows Promise in Treating Deadly Childhood Brain Cancer
去年
CAR-T Cell Therapy Shows Promise Against Deadly Childhood Brain Cancer in Clinical Trial
第 1 页,共 70 页
上一页
下一页